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ABSTRACT 
The presence of pharmaceuticals in the aquatic environment have raised concerns due 
to their possible threats to aquatic organisms. Currently, there is a lack of information about 
the adverse effects of pharmaceuticals in non-target organisms, mainly regarding long-term 
exposure at environmentally relevant concentrations. Selective serotonin reuptake 
inhibitors (SSRI) are among the most widely prescribed antidepressants worldwide and they 
have been detected at low levels in several aquatic systems. Nevertheless, the knowledge 
regarding chronic sublethal effects of SSRI in non-target aquatic organisms is scarce.  In 
humans, SSRI are designed to treat psychiatric disorders by modulating the 
neurotransmitter serotonin. However, in aquatic invertebrates, it seems to disrupt several 
biological functions such as reproduction, behavioural patterns and metabolism, among 
others. Sertraline (SER) was the SSRI selected for this ecotoxicological assay due to being 
described as the most toxic SSRI in some aquatic organisms. 
The aim of this study is the assessment of the ecotoxicological responses of the 
amphipod Gammarus locusta (Crustacea, Amphipoda, Gammaridae) chronically exposed 
to ecologically relevant concentrations of sertraline. A chronic bioassay (48 days) was 
conducted at low levels of SER (8, 40, 200, 1000 ng/L). An integration of ecological 
endpoints (survival, sex ratio, growth, reproduction and behaviour) and biochemical-level 
endpoints (glutathione S-transferase, catalase, superoxide dismutase, lipid peroxidation 
and acetylcholinesterase) was performed.  
SER affected the amphipods’ growth and lead to a non-monotonic response in activity 
of some biochemical markers. The most predominant effect of SER was a signiﬁcant impact 
on females’ behaviour exposed to 1000 ng/L SER. These results demonstrate that SER 
induces chronic effects on G. locusta, which may affect the wild populations of this species. 
The data here presented will further improve the understanding of the low level effects of 
SER in aquatic ecosystems; contributing for the advancement on the field of pharmaceutical 
risk assessment. Further studies should, however, be undertaken to provide additional 
insight into the multigenerational effects of SER, as well as on the toxicological mode of 
action SER in non-target organisms. 
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RESUMO 
A presença de fármacos no ambiente aquático tem suscitado uma grande 
preocupação, devido às suas possíveis ameaças para os organismos aquáticos. 
Atualmente há uma falta de informação sobre os efeitos adversos dos fármacos em 
organismos não-alvo, principalmente no que toca às exposições crónicas a concentrações 
ambientalmente relevantes. Os inibidores seletivos da recaptação da serotonina (ISRSs) 
estão entre os antidepressivos mais prescritos e têm sido detetados em vários sistemas 
aquáticos em concentrações residuais, ao nível do ng/L. No entanto, o conhecimento sobre 
os efeitos subletais crónicos que os ISRSs podem provocar em organismos não-alvo é 
escassa. Em humanos, os ISRSs são concebidos para o tratamento de problemas de 
índole psiquiátrica através da modulação do neurotransmissor serotonina. Contudo, em 
invertebrados aquáticos, parece modificar várias funções biológicas tais como a 
reprodução, padrões comportamentais e metabolismo, entre outros. A sertralina (SER) foi 
o ISRS selecionado para este ensaio ecotoxicológico por ser descrito como o mais tóxico 
em alguns organismos aquáticos. 
O objetivo deste estudo é avaliar as respostas ecotoxicológicas do anfípode 
Gammarus locusta (Crustacea, Amphipoda, Gammaridae) durante uma exposição crónica 
à sertralina, usando concentrações ecologicamente relevantes. Com este propósito, uma 
exposição de 48 dias foi realizada com baixas concentrações de sertralina (8, 40, 200, 1000 
ng/L). Foram analisados os efeitos provocados pela exposição da sertralina utilizando 
respostas ecológicas (sobrevivência, sex-ratio, crescimento, reprodução e comportamento) 
e bioquímicas (glutationa S-transferase, catalase, superóxido dismutase, peroxidação 
lipídica e acetilcolinesterase). 
SER afetou o crescimento dos anfípodes e causou uma resposta não-monotónica 
na atividade de alguns marcadores bioquímicos. O efeito mais evidente da sertralina 
consistiu na alteração da atividade de fêmeas quando expostas a 1000 ng/L de SER. Os 
resultados evidenciam que a exposição crônica de G. locusta a SER causa efeitos a 
concentrações ecologicamente relevantes e que estas poderão potencialmente afetar as 
populações no ambiente natural. Os resultados aqui apresentados permitirão melhorar a 
compreensão dos efeitos de baixas concentrações da SER em ecossistemas aquáticos; 
contribuindo assim para um melhor conhecimento sobre o risco deste fármaco. Novos 
estudos devem, contudo, ser efetuados para fornecer esclarecimentos adicionais sobre os 
efeitos multigeracionais de SER, bem como clarificar o modo de ação em organismos não 
alvo. 
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ABBREVIATIONS AND ACRONYMS 
µg Microgram 
AChE Acetylcholinesterase 
ANOVA Analysis of variance  
BHT Butylated hydroxytoluene 
BSA Albumin bovine serum 
CAT Catalase 
CDNB 1-chloro-2,4-dinitrobenzenE 
cm Centimetre 
CuSO4 Copper(II) sulfate 
EC50 Median Effective Concentration 
EDTA Ethylenediaminetetraacetic acid 
EU European Union 
FLU Fluoxetine 
FLU-d5 Fluoxetine-d5 
fps Frames per second 
GSH Reduced glutathione 
GST Glutathione-S -transfereses 
H2O2 Peroxide of hydrogen  
IS Internal Standard 
K2HPO4 Dipotassium phosphate 
KNaC4H4O6•4H2O Potassium sodium tartrate  
L Litre 
LC50 Median lethal concentration 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
LOEC Lowest observed effect concentration 
Log KOC Soil Organic Carbon-Water Partition Coefficient 
Log KOW Octanol-Water Partition Coefficient 
LPO Lipid peroxidation 
M Molar  
MDA Malondialdehyde 
min Minutes 
Na2CO3 Sodium carbonate 
NaOH Sodium hydroxide  
ng Nanogram 
nm Nanometer 
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NOEC No observed effect concentration 
O2•− Superoxide radical 
OECD Organisation for Economic Co-operation and Development 
PPCPs Pharmaceuticals and Personal Care Products 
ROS Reactive oxygen species 
s Seconds 
SER Sertraline 
SIR Selected Ion Recording 
SOD Superoxide dismutase 
SPE Solid phase extraction  
SSRIs Selective Serotonin Reuptake Inhibitors 
TBA Thiobarbituric acid 
TBARS Tiobarbituric acid reactive substances 
TCA Trichloroacetate 
WWTPs Wastewater Treatment Plants 
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1 INTRODUCTION 
1.1 STATE OF ART OF PHARMACEUTICALS IN AQUATIC ENVIRONMENT  
Awareness regarding pharmaceuticals in the aquatic environment was only possible 
in the 90’s due to advance of chemical analysis technology, which allows for the detection 
of these compounds at trace-level concentrations (Calisto and Esteves, 2009; Christen et 
al., 2010; Santos et al., 2010). The detection of pharmaceuticals in environment has been 
a growing concern due to the amount of new pharmaceuticals that are present at trace 
levels (Monteiro and Boxal, 2010). Pharmaceuticals are designed to produce specific 
biological effects in specific targets, being used for the prevention, diagnosis or treatment 
of diseases in humans and animals (Monteiro and Boxal, 2010). They may negatively affect 
non-target organisms if the molecular target, such as a receptor or enzyme, is conserved 
or if they have a homologous target, resulting in a specific pharmacological effect. This 
concept is known as read-across hypothesis (Christen et al., 2010; Ford and Fong, 2015; 
Franzellitti et al., 2014; Gunnarsson et al., 2012; Rand-Weaver et al., 2013). 
Pharmaceuticals have been found at low concentrations in the aquatic systems, so the 
adverse effects of these compounds in wild species seems to be a consequence of high-
affinity interactions. The aquatic organisms that possess the pharmaceuticals’ target 
preserved are most likely to be affected by pharmaceuticals, in comparison with species 
that do not have it (Gunnarsson et al., 2012). Thus, if the genome of non-target organisms 
is known, it becomes easier to predict whether the pharmaceutical has an effect. In 
particular, it is necessary to know if the organism has the target gene(s) in which the 
pharmaceutical will trigger their pharmacological activity. It is documented that aquatic 
vertebrates, such as Xenopus tropicalis and Danio rerio hold 80% of pharmaceutical 
molecular targets. This value is slightly lower for the invertebrates, being around 60% in 
Daphnia pulex (Gunnarsson et al., 2012; Rand-Weaver et al., 2013). Besides the 
pharmacodynamics response that may be detectable in non-target organisms it is 
fundamental to consider that side effects may also occur (Franzellitti et al., 2014).  
The exposure of aquatic organisms to pharmaceuticals occurs at low 
concentrations, within ng/L to µg/L range; so, lethal effects are not observed because these 
usually occur at higher concentrations in the order of mg/L, far from ecologically relevant. It 
is, therefore, most pertinent analyse sub-lethal and chronic effects of pharmaceuticals, 
since aquatic organism are continuously exposed to them at low concentrations, during their 
entire lifecycle or over multiple generations (Lamichhane and Garcia, 2014), which can lead 
to more serious consequences. So it is important to ascertain the potential long-term risks 
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of pharmaceuticals in aquatic organisms. However, previous research focused mainly in 
acute exposures (Ankley et al., 2007; Franzellitti et al., 2013), with concentrations above 
those found in the environment (Ankley et al., 2007; Kümmerer, 2010). Currently, there is 
still a low number of studies that report significant effects under environmentally realistic 
concentrations. As the concentrations of these compounds are very low in aquatic systems, 
studies indicate that these concentrations are well below of acute toxic levels, but there are 
uncertainties regarding the effects of chronic exposures (Franzellitti et al., 2013). Therefore, 
there is a need to focus on low-level and long term exposure assessment to better judge 
the implications of pharmaceuticals in aquatic environments (Lamichhane and Garcia, 
2014).  
 
1.1.1 SOURCE AND FATE OF PHARMACEUTICALS IN ENVIRONMENT 
Currently, there are thousands of active compounds being commercialized in the 
European Union (EU) (Calisto and Esteves, 2009), between these, nearly 3000 are used 
for human medicine (Christen et al., 2010; Fent et al., 2006). Pharmaceuticals have been 
found in several aquatic systems around the world (Kosma et al., 2014; Zhang et al., 2014).  
Their distribution is widespread and influenced by the consumption patterns (Silva et al., 
2014). After ingestion, some pharmaceuticals are metabolized while others remain in an 
unmetabolized form until they are eliminated (Kümmerer, 2010; Monteiro and Boxal, 2010). 
After their elimination, pharmaceuticals and their metabolites are discharged in hospital or 
municipal wastewater treatment plants (WWTPs), where removal processes will be applied 
(Monteiro and Boxal, 2010). The pharmaceuticals’ removal from WWTPs depends of their 
physicochemical characteristics, so many of them aren’t completely removed. Moreover, 
the efficiency of  same compound removal is variable (Fent et al., 2006; Monteiro and Boxal, 
2010; Zhang et al., 2014). This happens due to differences in WWTPs equipment and 
treatment protocols used as well as due to external factors such as weather conditions (Fent 
et al., 2006; Santos et al., 2007). Usually, the WWTPs use primary and secondary treatment 
stages for the removal process of pharmaceuticals; sometimes, it is also applied a tertiary 
treatment (Monteiro and Boxal, 2010). The first stage consists of a mechanical treatment 
where solids and greases are removed by coagulation and sedimentation processes 
(Monteiro and Boxal, 2010; Oulton et al., 2010; Santos et al., 2007). The secondary stage 
decreases the dissolved organic matter by activated sludge and biological filters (Monteiro 
and Boxal, 2010; Santos et al., 2007). It is in this stage that most pharmaceuticals are 
removed due to the activated sludge’s action (Monteiro and Boxal, 2010). In most advanced 
WWTPs, it is generally applied a third stage. This allows the nutrient reduction, such as 
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nitrates and phosphates, through chemical processes (Monteiro and Boxal, 2010; Santos 
et al., 2007).  
 After these treatments, the wastewater gets in the aquatic environment. However, 
these treatments are not specific for pharmaceuticals’ removal. So, as a consequence of 
an ineffective removal, pharmaceuticals have been found in the aquatic environment 
(Zhang et al., 2014). Still, the WWTPs contribute to the decrease of pharmaceutical 
concentrations  in aquatic systems (Monteiro and Boxal, 2010).  There are other sources of 
pharmaceuticals in the aquatic environment which are considered minor such as those from 
manufacturing processes and distribution  (Ellis, 2006; Monteiro and Boxal, 2010), the direct 
input through aquaculture facilities (Christen et al., 2010; Ellis, 2006; Fent et al., 2006) and 
the farming and agricultural activities. The last one includes the direct excretion of animals 
in the field (Christen et al., 2010; Kümmerer, 2010), the application of manure (Christen et 
al., 2010; Fent et al., 2006) or of sewage sludge (Fent et al., 2006; Monteiro and Boxal, 
2010) as fertilizers in agricultural activities (Figure 1). These contaminants flow into aquatic 
systems without going through any prior treatment (Ellis, 2006; Fent et al., 2006).  
Considering these scenarios, pharmaceuticals have been present in several aquatic 
systems like WWTPs’ effluents, surface water, groundwater and in drinking water (Christen 
et al., 2010; Fent et al., 2006). With the intention of removing their presence in the aquatic 
environment, it is necessary to achieve higher effectiveness in WWTPs treatments as well 
as a greater knowledge of “green pharmacy” where the development of easily degradable 
pharmaceuticals would be possible (Kümmerer, 2009).  
 
Figure 1: Schematic of sources and fates of PPCP’s in environment (Adapted from: Ellis, 2006; Lapworth 
et al., 2012;). 
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1.1.2 SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS: SERTRALINE 
One of the most prescribed group of pharmaceuticals are the psychiatric drugs, 
specifically the antidepressants (Calisto and Esteves, 2009). These compounds have 
therapeutic effects on the nervous system, regulate behaviour, reproduction and neuro-
endocrine responses of the target organisms (Calisto and Esteves, 2009).  
In average all of the EU member states increased the consumption of 
antidepressants by 80% in the last decade (OECD, 2012). Portugal has the highest use of 
antidepressants of the EU countries, with more 15% of the average reported for the EU 
countries (Eurobarometer, 2010). Currently, the antidepressants most prescribed in 
worldwide are the selective serotonin re-uptake inhibitors (SSRIs) (Silva et al., 2012), that 
have been commercialized since 1980’s (Silva et al., 2015). Among the SSRI, Fong and 
Ford, (2014) reported that sertraline (SER) is one of the most commonly prescribed 
antidepressants in the world. In United States the consumption of SER arise and became 
the 3rd psychiatric drug more prescribed (Lamichhane and Garcia, 2014). In Portugal the 
most consumed antidepressant was fluoxetine (FLU) until 2008. From that moment on, SER 
has been the most prescribed antidepressant in Portugal (Furtado, 2012).  
Sertraline, fluoxetine, citalopram, paroxetine and fluvoxamine are among the SSRIs 
(Lamichhane and Garcia, 2014; Silva et al., 2012). The SSRIs are used as antidepressants 
for the treatment of psychiatric disorders in humans (Brooks, 2014; Lamichhane and Garcia, 
2014) like depression,  obsessive-compulsive behaviour, anxiety, personality  disorders and 
others (Bossus et al., 2014; Di Poi et al., 2013; Rodrigues et al., 2015). The SSRI acts by 
inhibiting serotonin reuptake on cell membranes leading to elevated levels of serotonin in 
the nerve synapses, stimulating serotoninergic neurons (Fent et al., 2006; Henry and Kwon, 
2004). The serotonin is a neurotransmitter responsible for influencing the proper operation 
of the nervous and hormonal systems (Fent et al., 2006; Franzellitti et al., 2013; Minagh et 
al., 2009). Additionally, this neurotransmitter can change appetite, influence behaviour and 
modify sexual function (Fent et al., 2006). This pathways seems to be well conserved across 
Table 1: Properties of sertraline (Adapted from: DeVane et al., 2002). 
Formula C17H17NCl2 
Molecular weight 305.07 g/mol 
Biological Half-life 26 hours 
Solubility 3.52 mg/L 
Log KOW 1.37 
Log KOC 4.17 
Photolysis t½c 23 hours 
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metazoans and is found in both vertebrates and  invertebrates, although the mode of action 
is not known for all species (Campos et al., 2012; Silva et al., 2015). 
It is known that SSRIs have undesirably effects on the non-target organisms. In 
aquatic organisms it is reported that SSRIs can alter several biological functions. Among 
them are: alteration of reproduction pattern in Daphnia magna (Flaherty and Dodson, 2005) 
and Ceriodaphnia dubia (Brooks et al., 2003a) induction of spawning in zebra mussels 
Dreissenna polymorpha and fingernail clams Sphaerium striatinum (Fong, 1998) cause 
abnormalities in the embryonic development of Japanese medaka Oryzias latipes (Brooks 
et al., 2003a), cause delay in sexual maturation in male goldfish Carassius auratus 
(Mennigen et al., 2010), affect the metabolism  in the mussel Lampsilis fasciola (Hazelton 
et al., 2014) and decrease the growth of the fish Pimephales promelas (Stanley et al., 2007). 
Some behaviour alterations were also associated with action of SSRI such as 
aggressiveness in decapod crustaceans (Doernberg et al., 2001), alteration of ventilation 
and swimming activities of Gammarus pulex  (De Lange et al., 2009, 2006) and affect the 
cilia action in gastropods Physa elliptica (Uhler et al., 2000). Several authors have reported 
that some SSRI tend to bioaccumulate in aquatic organisms, in particular in fish (Brooks et 
al., 2005) and bivalves (Franzellitti et al., 2014). Most of the SSRI studies focuses on FLU, 
while there are few studies addressing the effects of SER in aquatic organisms (Park et al., 
2012). 
SER (Table 1) was the SSRI selected for this study, because it is reported to be the 
most toxic of this class to the aquatic species (Conners et al., 2009; Minagh et al., 2009; 
Park et al., 2012). SER is detected at low concentrations in the environment, at ng/L range 
(Table 2). 
1.1.3 ECOTOXICITY OF SERTRALINE 
Studies about the antidepressants effects in non-target aquatic organism are 
needed. Currently, the ecotoxicological research about antidepressants focuses mainly on 
acute toxicity assays (Franzellitti et al., 2013) and uses higher concentrations than those 
that are currently found in the environment. Thus chronic toxicity and potential subtle effects 
are slightly known (Fent et al., 2006). However, considering that aquatic organisms are 
uninterruptedly exposed to these compounds, a chronic approach is more relevant (Ankley 
et al., 2007).  
Since the adverse effects of antidepressants, namely SSRI, are not completely 
known, their impacts in aquatic environment are difficult to predict (Zhang et al., 2014). As 
SSRI act through the regulation of serotonin and since this neurotransmitter is present in 
both vertebrate and invertebrate (Fent et al., 2006), effects in aquatic organisms are 
expected. As previously mentioned, SER was found to be the most toxic SSRI for aquatic 
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organisms (Christensen et al., 2007; Henry and Kwon, 2004). In literature, it is documented 
that SER has been detected in tissues of aquatic organisms, such as crabs (Rodrigues et 
al., 2015) and of fish (Brooks et al., 2005; Schultz et al., 2011). So, the toxicity of SER is 
potentially greater for these aquatic organisms that accumulate this compound.  
The toxicity effects of SER were described in several studies. Henry et al. (2004) 
showed that 8 days exposure to SER lead to a lower number of neonates per female in C 
dubia. Also, Lamichhane and Garcia (2014) showed that, an chronic exposure to SER leads 
to fecundity and growth effects in C dubia, in addition to multigenerational effects 
(Lamichhane and Garcia, 2014). The assess of the effects of SER on ecological endpoints 
revealed a reduced growth in tadpoles Xenopus laevis in a chronic assay consisting of 70 
days of exposure (Conners et al., 2009). This reduced growth was also observed in tadpoles 
Lithobates sylvaticus when these were raised with conspecifics (Carfagno and Fong, 2014). 
Modifications in behaviour were also described after a SER exposure. In Echinogammarus 
marinus a significant increase in velocity was detected after 1 day of exposure (Bossus et 
al., 2014). In male fathead minnows an increase of shelter-seeking behaviour was seen 
after a chronic 28 days exposure (Valenti et al., 2012). The main toxicological data of SER 
are summarized in table 3. The data from table 3 shown that there is a lack of knowledge 
Table 2: Environmental concentrations of sertraline reported in literature (ng/L). 
Local Concentration Reference 
Surface water 
n.d.(a) (Batt et al., 2008) 
d.(b) (Vasskog et al., 2008) 
0.84 (Lajeunesse et al., 2008) 
2.4 (Lajeunesse et al., 2008) 
16.4 (Schultz et al., 2010) 
37.5 (Schultz et al., 2010) 
Wastewater effluent 
1.6 (Vasskog et al., 2006) 
2.0 (Vasskog et al., 2006) 
3.7 (Vasskog et al., 2008) 
5.1 (Lajeunesse et al., 2008) 
5.8 (Lajeunesse et al., 2008) 
12.6 (Vasskog et al., 2008) 
14.6 (Vasskog et al., 2008) 
34 (Metcalfe et al., 2010) 
49 (Schultz and Furlong, 2008) 
57 (Batt et al., 2008) 
75 (Batt et al., 2008) 
87 (Batt et al., 2008) 
100 (Weigel et al., 2004) 
(a) n.d. – Not detected 
(b) d. - Detected but below quantification limit (0.52 ng/L) 
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about the chronic effects of SER in aquatic organisms, particularly at environmentally 
relevant concentrations. 
Table 3: Sertraline toxicological endpoints reported in literature. 
Species 
Concentration 
(µg/L) 
Parameter 
measured 
Toxicological 
endpoint 
Exposure 
time 
Reference 
Ceriodaphnia 
dubia 
45 LOEC(a) Reproduction 8 days 
(Henry and 
Kwon, 2004) 
9 NOEC(b) Reproduction 8 days 
(Henry and 
Kwon, 2004) 
120 LC50(c) Mortality 48 hours 
(Henry and 
Kwon, 2004) 
53.4 LOEC 
Fecundity and 
growth (1st 
and 2nd 
generation) 
7 days 
(Lamichhane 
and Garcia, 
2014) 
4.8 LOEC 
Fecundity and 
growth (3rd 
generation) 
7 days 
(Lamichhane 
and Garcia, 
2014) 
Daphnia  
magna 
66 EC50(d) Reproduction 21 days 
(Minagh et 
al., 2009) 
100 LOEC Reproduction 21 days 
(Minagh et 
al., 2009) 
120 LC50 Lethality 21 days 
(Minagh et 
al., 2009) 
32 NOEC Lethality 21 days 
(Minagh et 
al., 2009) 
100 LOEC Lethality 21 days 
(Minagh et 
al., 2009) 
Echinogammarus 
marinus 
0.01 LOEC Velocity 24 hours  
(Bossus et 
al., 2014) 
0.001 NOEC Velocity 24 hours 
(Bossus et 
al., 2014) 
Thamnocephalus 
platyurus 
400 NOEC Lethality 24 hours 
(Minagh et 
al., 2009) 
600 LOEC Lethality 24 hours 
(Minagh et 
al., 2009) 
Oncorhynchus 
mykiss 
380 LC50 Lethality 96 hours 
(Minagh et 
al., 2009) 
320 LOEC Lethality 96 hours 
(Minagh et 
al., 2009) 
100 NOEC Lethality 96 hours 
(Minagh et 
al., 2009) 
Pimephales 
promelas 
80.3 EC50 Feeding rate 7 days 
(Valenti et 
al., 2009) 
3 LOEC 
Behaviour 
pattern 
28 days 
(Valenti et 
al., 2012) 
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Table 4: Continued 
Species 
Concentration 
(µg/L) 
Parameter 
measured 
Toxicological 
endpoint 
Exposure 
time 
Reference 
Xenopus 
 laevis 
0.1 LOEC Growth 70 days 
(Conners et 
al., 2009) 
0.1 LOEC Development 70 days 
(Conners et 
al., 2009) 
(a) LOEC - Lowest Observed Effect Concentration 
(b) NOEC - No Observed Effect Concentration 
(c) LC50 - Median Lethal Concentration 
(d) EC50 - Median Effective Concentration 
1.2 THE USE OF GAMMARUS LOCUSTA IN ECOTOXICOLOGICAL STUDIES 
Gammarids are crustacean amphipods with a wide distribution in aquatic 
environments, having been found in marine, freshwater and estuarine habitats (Whiteley et 
al., 2011). These organisms are particularly abundant and widely spread in the northern 
hemisphere (Hou et al., 2007; Whiteley et al., 2011). They fulfil an important role in the 
aquatic eco system, especially in food chains and in the decomposing of particulate organic 
matter (Bossus et al., 2014; De Lange et al., 2006), they are an important food source for 
fishes, birds, amphibians, seals and invertebrate species (Peschke et al., 2014; Vellinger et 
al., 2012; Whiteley et al., 2011), which significantly contributes to its high ecological value 
(Costa et al., 1998; Vellinger et al., 2012). Due to these features, gammarids are refereed 
as an important representative of invertebrates (Peschke et al., 2014).  
Gammarids have been used in ecotoxicology studies due to their sensitivity to an 
extensive variety of contaminants (Geffard et al., 2010; Neuparth et al., 2014b; Peschke et 
al., 2014). Furthermore, they are easy to maintain in the laboratory (Geffard et al., 2010; 
Whiteley et al., 2011), have short generation time (Minagh 
et al., 2009; Peschke et al., 2014) and exhibit high 
reproductive rates (Neuparth et al., 2014b; Peschke et al., 
2014). Moreover, these organisms have the benefit of not 
causing ethical problems as fish and other invertebrates 
(Neuparth et al., 2014b). These amphipods have been 
used as sentinel, indicating changes in environmental 
parameters. There is an increase of research using these 
organisms (Whiteley et al., 2011).  
The Gammarus genus has been used in several 
ecotoxicological research (Costa et al., 1998; De Lange et 
al., 2006; Neuparth et al., 2014b, 2005; Peschke et al., 
2014; Vellinger et al., 2012). In Europe, there is an 
estimated occurrence of 100 species of Gammarus genus Figure 2: A couple of Gammarus 
locusta  
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(Hou et al., 2007), among them is the Gammarus locusta (L., 1758) (Figure 2) (Neuparth et 
al., 2014b). This species is epibenthic and shows a wide geographic distribution appearing 
in locations from northern Norway to southern Portugal (Costa et al., 2004, 1998; Neuparth 
et al., 2014b; Whiteley et al., 2011) and is quite abundant in the Sado estuary (Costa et al., 
1998). The presence of this specie in Portuguese coast, along with its ecological importance 
and its sensitivity to contamination, make G.locusta the chosen organism to perform the 
study presented in this thesis.  
1.3 METHODOLOGIES USED IN THE STUDY 
The chronic sub-lethal effects of SER were investigated through the analysis of 
ecological endpoints (survival, sex-ratio, growth, reproduction and behaviour analysis) and 
biochemical markers (glutathione S-transferase (GST), catalase (CAT), superoxide 
dismutase (SOD), lipid peroxidation (LPO) and acetylcholinesterase (AChE). 
1.3.1 ECOLOGICAL ENDPOINTS 
When it becomes evident that a contaminant negatively affects the population, it is 
difficult to take precautionary measures because the consequences of exposure reached a 
point where it is no longer possible to reverse the risk (Van der Oost et al., 2003). So, it is 
necessary to study the effects in a lower level of the biological hierarchy (Figure 3). 
Generally, in ecotoxicological assays, a battery of traditional ecological endpoints such as 
survival, sex ratio, individual growth and reproduction are applied. These endpoints were 
chosen in this study for being sensitive and for allowing the detection of effects at low levels 
of contaminants. It is described in the literature that SER causes behavioural modifications, 
the behaviour analysis was also considered in this thesis to assist the interpretation of the 
responses observed in the traditional ecological endpoints (survival, growth and 
reproduction).  
 
Figure 3: Representation of the hierarchy of responses to an exposure. (Adapted from Van der Oost et al. 
2003). 
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1.3.2 BIOCHEMICAL ENDPOINTS 
 As a valuable complementary approach to the ecological endpoints typically 
analysed in ecotoxicological assays, biomarkers analyses were performed. Biomarkers 
related to biotransformation, oxidative stress and neurotransmission were selected because 
they could provide information about the health status of the organism. Moreover, the SER 
mechanism of action might interfere with oxidative stress and the AChE activity (Xie et al., 
2015).  
Antioxidant enzymes were analysed for being essential in maintaining the cellular 
homeostasis whenever oxidative stress occurs. The antioxidant enzymes selected were 
CAT and SOD activity for being the leading agents in preventing oxidative stress (Chen et 
al., 2015; Xie et al., 2015). The GST was chosen due to its ability to not only protect cells 
from oxidative stress but also catalyse the conjugation of xenobiotics with glutathione, 
facilitating their elimination from the organism (Chen et al., 2015; Van der Oost et al., 2003; 
Xie et al., 2015). LPO was analysed in order to verify the existence of oxidative damage in 
lipids, since lipids are important molecules as they aid with cellular integrity (Valavanidis et 
al., 2006) and can be an energy source (Correia et al., 2003). 
As a neurotoxicity biomarker we analysed the AChE enzyme due to its role in 
regulating the nervous transmission (Xie et al., 2015). Besides, in literature it is reported 
that SER might influence the cholinesterase activity in crabs (Rodrigues et al., 2015). 
1.4 OBJECTIVES  
The main objective of this thesis is to evaluate the biological responses of G. locusta 
following chronic exposure to environmental relevant concentrations of SER. An integration 
of multiple key ecological endpoints (survival, sex ratio, individual growth, reproduction and 
behaviour analysis) with biochemical markers, indicative of oxidative stress (catalase, 
glutathione S-transferase and superoxide dismutase activities and lipid peroxidation levels) 
and neurotransmission, were determined.   
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2 MATERIALS AND METHODS 
2.1 AMPHIPOD CULTURE 
Gammarus locusta amphipods were obtained from a permanent laboratory culture 
developed at CIIMAR. This culture has been kept for several generations in the laboratory. 
The maintenance of the G. locusta culture is dependent on amphipods collected once a 
year from a clean site in Sado estuary, Portugal, (N 38º 27’, W 08º 43’),  where a population 
of G. locusta is abundant (Neuparth et al., 2002). The organisms were maintained in plastic 
aquaria with controlled conditions: temperature 18 ± 2ºC, photoperiod 16h light: 8h dark and   
salinity 33–35‰. In each aquarium, a clean sediment layer up to 1cm and small stones 
were added to provide shelter. The animals were fed with Ulva sp (Costa et al., 1998; 
Neuparth et al., 2014b), and aeration was provided with plastic tips. The algae was collected 
from a local considered reference site in a beach at Vila Nova de Gaia, Portugal (N 41º 3’ 
29.17’’, W 8º 39’ 23.39’’) and sediment and stones were collected in Mindelo beach, Vila do 
Conde, Portugal (N 41º 18’ 35.24’’, W 8º 44’ 25.06’’). 
The amphipods were distributed by three size’s classes (adults, juveniles and 
newborns) due to the occurrence of cannibalism verified in this species (Correia et al., 2002; 
Costa et al., 2005). In order to distribute the animals into the different size classes, twice a 
week the water of each aquarium was sieved through a battery of screens with decreasing 
mesh size (1500, 500 and 250 µm). 
2.2 CHEMICALS  
Sertraline hydrochloride (CAS 79559-97-0, purity ≥98.0%) was purchased from 
Sigma-Aldrich®. The fluoxetine-d5 hydrochloride (FLU-d5) (CAS 1173020-43-3; purity 
=98%), also purchased from Sigma-Aldrich® was used an internal standard for water SER 
quantification. 
2.3 EXPERIMENTAL BIOASSAY 
2.3.1 EXPERIMENTAL DESIGN 
The bioassay, with a duration of 48 days, was conducted in 7 L aquaria with 20 
amphipods each in a semi static system. Sub-adults were picked from the culture in order 
to start the chronic exposure. The bioassay was designed to study the effects of sertraline 
in a range of ecological (survival, sex ratio, individual growth and reproduction) and 
biochemical (oxidative stress and neurotransmission biomarkers – GST, CAT, SOD, LPO 
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and AChE levels) endpoints. During the test, the organisms were maintained in the same 
photoperiod, salinity and temperature of the culture system. The aquaria had a clean 
sediment layer up to 1 cm, small stones and aeration provided with plastic tips. The animals 
were fed ad libitum with Ulva sp. which was collected regularly at the clean site mentioned 
above in 2.1. In each aquaria, alongside with Ulva sp., commercial ﬁsh pellets, were added 
in order to decrease the cannibalism that occurs in Gammarus sp. (MacNeil et al., 2003; 
Vellinger et al., 2012).  
After one week of acclimation, amphipods were exposed to SER. Five experimental 
conditions with three replicates each were considered: one control (natural sea water 33‰) 
and four SER treatments with nominal concentrations of 1000, 200, 40 and 8 ng/L. A stock 
solution was prepared in ultra-pure water at 100 mg/L and stored in dark at 4ºC. The test 
solutions of SER were prepared by successive dilution of the stock solution and directly 
applied to each aquarium every two days. 
The aquaria were inspected daily for feeding requirements, assuming that Ulva sp 
is never in shortage, for aeration or to remove dead animals. The water was exchanged 
every 48 hours and the SER nominal concentrations were renewed in every water change. 
pH, conductivity, dissolved oxygen and ammonia concentration were measured before each 
water change.  
At 21st, 31st and 40th days of the beginning of bioassay, the aquaria were sieved 
through 1500 and 250 µm mesh sieves to collect, respectively, adults and newborns. To 
ensure that all newborns are collected the aquaria were rinsed twice and sieved. The 
newborns were preserved in 70% ethanol with Bengal rose for later determination of 
newborns production per female (Costa et al., 2005). The adults were put back in their 
respective aquarium. At the end of the bioassay (day 48) all the aquaria were sampled and 
the individual and biochemical endpoints were determined as described in section 2.4 and 
2.5, respectively. 
2.4 ECOLOGICAL ENDPOINTS 
The adults collected in the 1500 µm mesh sieve were used for ecological endpoints 
determination. The newborns collected in the 250 µm mesh sieve were preserved for the 
aforementioned determination. The ecological endpoints analyzed comprised survival, sex 
ratio, individual length, reproduction and behavior and were determined separately in each 
replicate for each sex. Survival was expressed as a percentage relative to the initial number 
of organisms. The sex ratio was determined dividing the number of males by the number of 
females. The individual length was defined as the individual size of the organism at the end 
of the assay. For this determination the metasomatic length was used. The metasomatic 
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length, that is defined as the distance between the anterior end of the rostrum and the 
posterior end of the last metasomatic segment (Costa et al., 2005; DeWitt et al., 1992; 
Neuparth et al., 2014b), was measured using a stereomicroscope (Nikon SMZ 1000).  
The behavioural analysis was based on video recordings. For each treatment, nine 
organisms per sex, which were randomly selected, were placed individually in one petri dish 
(diameter 8.5 cm, height 1.5 cm). In each video, six organisms were recorded at the same 
time. Individual behaviour was recorded in each petri dish full of water of the respective 
treatment. The video recording was made in a lit environment in the same room where the 
bioassay was conducted. After 5 min of acclimation, the amphipods´ movement were 
recorded for 5 min with a HD digital camera (C525, Logitech). The video was obtained in 
Windows Media Video file (extension .wmv) in 15 frames per second (fps), and it was 
converted in pictures (extension .jpeg) in 5 fps with iWisoft Free Video Converter (it was 
download in “http://www.iwisoft.com/videoconverter/”). The data analysis was made with 
image J with the particle tracker plugin (downloaded in “http://mosaic.mpi-
cbg.de/?q=downloads/imageJ”). The behavioural endpoint analysis was the total distance 
covered by the organism. 
2.5 BIOCHEMICAL ENDPOINTS 
After the ecological endpoint analyses all males and females were frozen in liquid 
nitrogen and conserved at -80ºC until further determination of the oxidative stress (CAT, 
SOD and GST activities and LPO level) and neurotransmission (AChE) biomarkers, which 
were determined separately by males and females according to the methods described 
below. Pools of bodies of 1 or 2 males and 2 or 3 females (approximately 0.1 g) were used 
for CAT, SOD, GST and LPO determinations and pools of 2 males or 2 females heads 
(approximately 0.050 g) were used for AChE determination. All the tissues were 
homogenised in ice-cold phosphate buffer (KPi 100 mM, 1 mM EDTA, pH 7.5). The 
homogenized solution was centrifuged at 12 000G, during 20min at 4ºC. The cytosolic 
phase (supernatant) was stored at -80ºC in several aliquots for the different biochemical 
analysis. 
2.5.1 PROTEIN DETERMINATION 
The amount of protein present in each sample was determined in triplicate using the 
Lowry’s method with albumin bovine serum (BSA) as standard. This method was based on 
the formation of a copper-protein complex and the reduction of Folin-Ciocalteu 
(phosphomolybdate - phosphotungstate), yielding a change in colour which was quantified 
by spectrophotometry  
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Eleven standard solutions of BSA were prepared through a dilution of BSA stock 
solution (38 mM). 100 µL of standard solutions were added to microplate wells in triplicate, 
and samples (5 µL sample and 95 µL ultrapure water) were added in the following wells 
also in triplicate. The mix of solution A-B (previously prepared) was added to all wells and 
was incubated for 10 min. The solution A consisted of 0.2 M sodium carbonate (Na2CO3), 
0.001 mM potassium sodium tartrate (KNaC4H4O6·4H2O) and 0.1 M sodium hydroxide 
(NaOH). The solution B was obtained with a drop of sulphuric acid (H2SO4), 30mM copper(II) 
sulfate (CuSO4) and deionized water. Lastly, the Folin reagent was placed in all wells and, 
after incubating in the shaker for 30 min, the absorbance was read at 690 nm. 
2.5.2 GLUTATHIONE-S-TRANSFERASE  
The GST activity was measured by spectrophotometry at 340 nm, using the methods 
described by Habig et al. (1974), adapted to microplate. The 1-chloro-2,4-dinitrobenzene 
(CDNB) was used as substrate of GST in order to form a conjugate with the reduced 
glutathione (GSH). The GST activity was measured by the formation of this conjugate. 
Prior the assay, 10 mM GSH was prepared in the GST buffer (0.1 M phosphate 
buffer, pH 6.5) and 60 mM CDNB in ethanol. The reaction buffer was made with 
GST:GSH:CDNB in 4.95:0.9:0.15 mL, proportion. In the wells of the microplate, 50 µL of 
sample and 50 µL of GST buffer were added. A blank was performed, also in triplicate, by 
adding 50 µL of GST buffer instead of sample. Afterwards, the reaction buffer was added 
to start the reaction. The absorbance was recorded during the first 5 min, at intervals of 20 
s. GST activity is expressed in ηmol/min/mg protein (Ferreira et al., 2010). 
2.5.3 CATALASE  
CAT activity was measured by spectrophotometry, using a microplate specific for 
ultraviolet light readings. The method measures the depletion of the hydrogen peroxide 
(H2O2) at 240 nm. The reaction’s solution was made with 0.05 mM phosphate buffer pH 7.0 
and H2O2 (30%). The absorbance was measured with 135 µL of phosphate buffer, 15 µL of 
sample and 150 µL of the reaction’s solution. Spontaneous substrate hydrolysis was 
assessed using a blank without the sample, in triplicate. The results were recorded during 
1 min, at intervals of 10 s. The activity of CAT was expressed as µmol/min/mg protein 
(Ferreira et al., 2010). 
2.5.4 SUPEROXIDE DISMUTASE 
The SOD activity was measured indirectly. The cytochrome c was used as 
exogenous compound to compete with the endogenous SOD for superoxide radical (O2•−). 
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The assay consists in inducing the formation of hydrogen peroxide (H2O2) in the cells, by 
the xanthine oxidase, according to the reaction:  
Xanthine + H2O + O2  Uric acid + O2•− + H+ 
After the cytochrome c was added, a competition occurred between cytochrome c 
and SOD for the degradation of O2•−. Oxidised cytochrome c is reduced by the superoxide 
radical. The reaction occurs as follows: 
O2•− + cytochrome c (Fe 3+)  O2 + cytochrome c (Fe 2+) 
Superoxide dismutase inhibits the reduction of cytochrome c by competing for the 
superoxide radical. The reaction occurs as follows: 
2 O2•− + 2 H+  H2O2 + O2 
The reduction of cytochrome c was quantified by spectrophotometry at 550 nm, 
through the changes in colour. So, the greater the reduction of cytochrome c, the smaller 
the amount SOD present. 
A measuring unit of the SOD activity is defined as the amount that causes 50% of 
inhibition of the reduction of your exogenous competitor (in this case cytochrome c) per mg 
of protein (Ferreira et al., 2010). 
The standard solutions of SOD enzyme were prepared from dilutions from the stock 
solution (3000 U/mL). 25 µL of the standard solution were added to the wells, as well as 25 
µL of samples and 25 µL of SOD buffer to serve as blank, all in triplicate. Then, 25 µL of 
SOD buffer were added in all wells. Subsequently, 200 µL solution A were added, and 50 
µL of solution B were placed after. The solution A consisted of 0.7 µM xanthine solution, 30 
µM cytochrome c and 50 mM phosphate buffer, and the solution B was obtained with 
xanthine oxidase 0.4 U/mL and 0.1 M Na2EDTA. The absorbance was read at 550 nm, 
every 20 s, during 5 min. 
2.5.5 LIPID PEROXIDATION  
The quantification of the peroxidative damages of lipids was performed by the 
determination of thiobarbituric acid reactive substances (TBARS). The LPO level was 
determined by analysis of malondialdehyde (MDA) content using the thiobarbituric acid 
(TBA) method. The MDA is a secondary product of lipid peroxidation, and is a major product 
formed. The MDA precipitate with TBA, and, consequently, an increase of absorbance will 
occur which can be easily assessed with a spectrophotometer (Del Rio et al., 2005). 
Trichloroacetate (TCA) 100% was added to the tissue samples, stirred by vortex and 
centrifuged at 12 000 G, during 20 min at 4ºC. The supernatant was collected and 0.1 M 
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EDTA, TBA 1%, 0.05 M NaOH and butylated hydroxytoluene (BHT) 0.025% were added. A 
blank was prepared using the same procedure but rather than supernatant, ultra-pure water 
was added. Then, the mixture was boiled for 30 min and left to cool down before reading 
the absorbance at 532 nm. All the samples and the blank were read in triplicate. The LPO 
is expressed as ηmol of MDA equivalents per mg of protein (Ferreira et al., 2010). 
2.5.6 ACETYLCHOLINESTERASE 
The Ellman method was used to determine the AChE activity (Lionetto et al., 2003). 
Acetylthiocholine was used as substrate. The 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) 
formed adducts with the thiocholine produced from the degradation of acetylthiocholine by 
AChE. The AChE’s activity was measured by spectrophotometry at 412 nm and was 
expressed as ηmol/min/mg protein. The reaction’s solution was made with 0.1 M phosphate 
buffer, pH 7.2, 0.1 M acetylthiocholine and 10 mM DTNB. In the microplate wells, 50 µL of 
sample and 250 µL of reaction solution were added, in triplicate. Also, in triplicate, a blank 
was made to assess the spontaneous substrate hydrolysis. This blank was made by placing 
50 µL of 0.1 M phosphate buffer instead of sample. The absorbance was read at 412 nm 
through the microplate reader, during 5 min in intervals of 20 s. 
2.6 SERTRALINE QUANTIFICATION  
In each treatment, the actual concentration of SER was determined by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS), at zero hours after one of the 
water change (time 0) and 48 hours, immediately before the next water change. Two 
samples of water per treatment (bulk samples collected from each treatment replicate) were 
extracted and quantified by LC-MS/MS as described in the next sections.  After collection, 
the samples were frozen at -20ºC until the analysis. 
2.6.1 SAMPLE EXTRACTION 
After thawing overnight in dark, at room temperature, the water samples were 
extracted by solid phase extraction (SPE) using cartridges from Strata™-XL-C 100 µm 
Polymeric Strong Cation (500 mg/6 mL), obtained from Phenomenex, on a vacuum 
extraction manifold. Previously, the cartridges were conditioned with 10 mL of acetonitrile 
followed by 10 mL 100 mM dipotassium phosphate (K2HPO4) pH 7.9. Then, the water 
sample was loaded into the cartridges. After, the cartridges were washed with 10 mL 100 
mM dipotassium phosphate pH 7.9 followed by 10 mL of methanol and were dried in 
vacuum for 10 min. Lastly, the samples were eluted with 10 mL of Ammonium 
Hydroxide:Acetonitrile in the proportion of 5:95. Following the extraction procedure, the 
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extracts were frozen at -20ºC in glass vials with a nitrogen gas, in the dark. Then the extracts 
were evaporated under nitrogen steam and were reconstituted with 190 µL of acetonitrile. 
Finally, 10 µL of internal standard were added at 1 µg/mL in all reconstituted extracts and 
were analysed by LC-MS/MS. 
2.6.2 LC-MS/MS 
Samples were injected in a liquid chromatograph, Waters Alliance e2695 HPLC, 
coupled with a Mass Spectrometry detector Micromass® Quattro Micro Api™ (Waters, MA, 
USA), with a chromatographic SB-C18 columns (Zorbax 50 mm x 4.6 mm; 1.8 µm particle 
size) (Agilent Technologies, USA). The separation was performed with acetonitrile and 
0.1% formic acid in ultra-pure water as mobile phase. The gradient of mobile phase 
applied was as follows: solvent (A) acetonitrile and solvent (B) 0.1% formic acid in ultra-
pure water at a flow rate of 0.150 mL/min. The sample volume injected was 1 µL and 
the following gradient was applied: initially from 0 to 5 minutes, 50% of each gradient 
was applied; then, from 5 to 7min, 75% of (A) and 25% of (B); finally, from 7 to 15 min, 
50% of each gradient was applied, once more, with a total run time of 15 min. The MS 
parameters were defined as follows: source temperature 120ºC, desolvation nitrogen 
flow 650 L/Hr at 300ºC, capillary voltage 2.46 kV; cone 30.0 V; extractor 2.0 V; 
resolution (LM1, HM1, LM2, HM2) 10.0; ion energy 1 and 2 1.0; entrance 10.0; exit 9.0; 
multiplier 650 V. Samples were injected and analysed in a positive mode by its 
precursor and fragment ions (table 4) in selected ion recording (SIR) and full scan (100-
500 m/z) modes. Tune method was performed with a SER and FLU-d5 standard 
solutions (2.3 µg/mL and 1 µg/mL, respectably). The carryover test of the method was 
also performed. Collected data was interpreted using MassLynx™ 4.1 SCN 805 
software. 
Table 5: Mass spectrometer settings [M+H+] 
Compounds 
Parental 
ion 
Fragment 
Ion 
Reference 
Fluoxetine-d5 315 44 
(Gros et al., 2012; Lamichhane and Garcia, 2014; 
Petrović et al., 2014) 
Sertraline 306 
159 
(de Castro et al., 2008; Gros et al., 2012; Petrović 
et al., 2014; Zhang et al., 2011) 
276 
(de Castro et al., 2008; Lamichhane and Garcia, 
2014; Petrović et al., 2014) 
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2.7 STATISTICAL ANALYSIS 
Statistical analysis were conducted using Statistica 12.6 software from StatSoft, 
Inc®. The normality of data was determined using the Kolmogorov-Smirnov test and the 
homogeneity of variances was verified by the Levene’s test. The data from ecological 
(survival, sex ratio, length, reproduction and behaviour) and biochemical endpoints (CAT, 
SOD, LPO and AChE) were analysed by one-way analysis of variance (ANOVA) to verify if 
significant differences between exposed and control organisms, could be associated to 
sertraline exposure. Treatments that did not fulfil the assumption of ANOVA were previously 
transformed. In all analysis, after ANOVA, differences between groups were established 
using post hoc Fisher’s test at 0.05 of significance level. For GST, because ANOVA 
assumptions were not fulfilled, a Kruskal-Wallis ANOVA by ranks was performed using a 
level of significance of p=0.05.  
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3 RESULTS 
3.1 ECOLOGICAL ENDPOINTS 
The mean total survival obtained separately for males and females in each SER 
treatment after 48 days of exposure is presented in figure 4. Survival rate of control 
organisms was 80% and 67%, for males and females respectively. These control survival 
rates are within the normal expected values for long term bioassays with G. locusta  
(Neuparth et al., 2014a). Cannibalism most likely accounts for a signiﬁcant portion of control 
mortality in laboratory tests with this species (Costa et al., 2005; MacNeil et al., 2003). The 
survival did not differ significantly between control and SER exposed groups. The males’ 
survival rate in SER treatments was within a range of 50-80% whereas the females’ survival 
rate was between 37-67%. 
 
Figure 4: Percentage of survival of Gammarus locusta males and females after chronic exposure to sertraline. 
Error bars indicate the standard errors. 
No significant differences were observed in sex-ratio among the SER treatments 
and control group figure 5. Variations occurred at 40, 200 and 1000 ng/L SER 
concentrations, leading to a prevalence of males’ survival in these treatments.  
 
Figure 5: Sex ratio of Gammarus locusta after chronic exposure to sertraline. Error bars indicate the standard 
errors. 
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The analysis of individual growth was performed separately by gender.  
 
 
Figure 6: Chronic effects of SER on Gammarus locusta growth after a chronic exposure in (A) females and (B) 
males. Error bars indicate the standard errors. Differences between results are identified by different letters. 
In females, the average length at 8 ng/L was statistically higher than the two higher 
concentrations (200 and 1000 ng/L), but none of them differs from control group (figure 6-
A). The males’ growth at 8 ng/L SER was statistically higher than the other concentrations 
(40, 200 and 1000 ng/L). The 40 ng/L SER concentration was significantly lower than the 
control group (p<0.03) and the lowest concentration tested (8 ng/L) (figure 6-B).  
Reproductive performance was analysed through the cumulative number of 
newborns produced per female during the assay.  
 
Figure 7: Cumulative number of newborns per female. Error bars indicate the standard errors. 
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No significant differences were found, neither between the SER treatments nor 
when these were compared to the control group (figure 7). 
The distance travelled by the amphipods by gender is shown in figure 8. For males, 
no significant differences were found among treatments. Whereas for females, an increase 
in activity was observed with the increase of SER concentration. At 1000 ng/L, the females’ 
activity was significantly higher than all the other treatments (p<0.05).  
 
Figure 8: Total distance travelled and average speed for Gammarus locusta males and females after a chronic 
exposure to sertraline. Error bars indicate the standard errors. Asterisks indicate significant differences from 
control group (p<0.05) 
3.2 BIOCHEMICAL ENDPOINTS 
3.2.1 ANTIOXIDANT BIOMARKERS 
GST, CAT and SOD activities of the G. locusta exposed to SER are presented in 
figure 9. Significant differences between treatments were found in all biomarkers of 
oxidative stress except for GST. 
Concerning CAT activity, a divergent response between genders occurs. No 
significant differences were found among treatments regarding males. Whereas for 
females, a higher activity was verified at 1000 ng/L of SER concentration when compared 
to the 8 ng/L. In males’ SOD activity, at 200 and 1000 ng/L concentrations, a significant 
activity’s reduction was found, when compared to the control group (p<0.01). In regard to 
females’ SOD activity, no significant differences were found. 
The LPO levels in males rose significantly at the 200 ng/L concentration when 
compared with the highest concentration tested (1000 ng/L), not occurring any differences 
in relation to females (Figure 10). 
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Figure 9: Levels of glutathione S transferase (GST), catalase (CAT) and superoxide dismutase (SOD) activities 
determined in Gammarus locusta males and females after a chronic exposure to sertraline. Error bars indicate 
the standard errors. Differences between treatments are identified by different letters 
 
       
Figure 10: Lipid peroxidation (LPO) levels determined in Gammarus locusta males and females after a chronic 
exposure to sertraline. Error bars indicate the standard errors. Differences between treatments are identified by 
different letters. 
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3.2.2 NEUROTRANSMISSION BIOMARKER  
There were no significant differences among experimental groups concerning AChE 
activity (figure 11).  
 
      
 
 
Figure 11: Acetylcholinesterase (AChE) activity determined in Gammarus locusta males and females 
after a chronic exposure to sertraline. Error bars indicate the standard errors. 
3.3 SERTRALINE QUANTIFICATION  
Table 5 summarizes the concentrations of SER measured once in the chronic assay. 
No SER was detected in the control group. Results show that SER concentrations at the 
initial time (time 0) were lower than nominal concentrations. After 48 h, immediately before 
the water change, the concentrations of SER were lower than initial time, with the exception 
of 8 and 200 ng/L.  
 
 Table 6: Nominal  and  measured  concentrations  of  sertraline  in  water  samples  collected  in  duplicate  
from  each  treatment. Data expressed as mean (ng/L) ± standard error 
Time Control 8 ng/L 40 ng/L 200 ng/L 1000 ng/L 
Time 0 n.d. (a) 4.8±2.2 24.1±0.2 90.6±53.3 675.7±50.1 
Time 48 n.d. (a) 8.2±0.4 13.1±10.0 115.0±0.6 275.6±52.1 
(a) Not detected. 
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4 DISCUSSION 
Pharmaceuticals have been detected in aquatic ecosystems at concentrations that 
might represent a risk for natural populations. Among pharmaceuticals, antidepressants, 
such as SSRIs, represent a global concern to the aquatic environment since they are widely 
prescribed (Fong and Ford, 2014; Rodrigues et al., 2015). However, the available data 
referring to the effects of SSRIs in aquatic organisms is still very limited in order to project 
the ecological costs associated with long term exposure. Today, it is known that SSRIs 
interacts with the serotonin levels (Silva et al., 2014) inhibiting its reuptake at the presynaptic 
membrane. This inhibition leads to an increase of serotonin level in the synaptic space, 
making the serotonin more prone to bind with postsynaptic receptors, thus stimulating the 
serotoninergic neurons (Campos et al., 2012; Conners et al., 2009; Lattimore et al., 2005; 
Park et al., 2012). The serotonin is a ubiquitous neurotransmitter found in vertebrates and 
invertebrates (Silva et al., 2015), but its function and the mechanism of action are not fully 
known for several species (Silva et al., 2015). Therefore, an effort has been made in order 
to address the lack of information about the effects of SSRIs in the environment. SSRIs are 
known for modifying the regulation of the serotonin neurotransmitter in both vertebrates and 
invertebrates. As such, it is probable that the cellular receptors for SSRI are evolutionarily 
conserved. Additionally, since serotonin adjusts hormonal and neurological mechanisms it 
is expected that non-target organisms may deal with identical responses or side effects as 
those observed in humans (Gonzalez-Rey and Bebianno, 2013; Schultz et al., 2011). Some  
side effects of SSRIs in aquatic organism are already documented in a few studies, such 
as changes in reproduction (Lamichhane and Garcia, 2014; Minagh et al., 2009) and in 
metabolism (Rodrigues et al., 2015; Xie et al., 2015).  
Among SSRI, FLU is the most studied (Silva et al., 2015); however, SER has been 
reported as the most toxic for aquatic organisms (Lamichhane and Garcia, 2014). Little is 
known on the effects of SER on aquatic organisms (Rodrigues et al., 2015), mainly 
considering chronic effects. SER concentrations on surface water are reported commonly 
at trace levels concentrations, but studies carried out with environmentally relevant 
concentrations of SER are scarce (Bossus et al., 2014). Some studies, using both acute 
and chronic exposures, reported that such SER concentrations can have a significant 
impact on aquatic organisms, such as reducing the survival of fish (Schultz et al., 2011), 
decreasing the tadpoles’ growth (Conners et al., 2009) and changing the swimming 
behaviour in gammarids (Bossus et al., 2014; De Lange et al., 2009). However, the 
mechanisms by which this pharmaceutical may affect aquatic organisms are unknown.  
A recent study of Bossus et al. (2014) reported significant changes in swimming 
behaviour of Echinogammarus marinus exposed to acute environmentally relevant 
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concentrations of SER (1 to 1000 ng/L). After 1 hour of exposure, the organisms showed 
higher activity at the concentration of 10 ng/L, but when the SER exposure lasted 8 days 
no significant differences were found, comparing to the control group. Taking into account 
the results of Bossus et al. (2014) showing that acute SER exposure at environmentally 
relevant concentrations exhibited effects in amphipod‘s behaviour, a long-term analysis of 
SER effects is fundamental as the aquatic organisms are exposed uninterruptedly, over 
their life cycles, to chronic low levels of SER. Thus, in the scope of this thesis, a chronic 
exposure during 48 days at environmentally relevant concentration of SER was performed 
with the amphipod G. locusta, in order to analyse the SER effects at various levels and to 
understand the its effects in the aquatic ecosystems.  
In the present study, SER induced several chronic adverse effects in G. locusta, 
both at ecological and at biochemical endpoints. In some endpoints, non-monotonic curves 
were obtained. These type of curves have been observed in other studies with 
antidepressants in aquatic organisms, where an absence of a dose dependent response is 
usual (Ford and Fong, 2015; Schultz et al., 2011). Non-monotonic responses are 
characterized by the curve’s slope inversion over the tested concentrations (EFSA, 2012; 
Vandenberg et al., 2012). The non-monotonic curves may exhibit a biphasic shape (Conolly 
and Lutz, 2004), a U-shape or an inverted U-shape (EFSA, 2012; Vandenberg et al., 2012). 
Some authors suggest that non-monotonic responses might be related to receptor 
desensitization or due to these having reached the maximum response (Bossus et al., 2014; 
Guler and Ford, 2010). The occurrence of modifications in metabolizing enzymes is another 
plausible explanation for this type of responses, since these modifications lead to an 
adaptive response (EFSA, 2012). 
4.1 ECOLOGICAL ENDPOINTS 
 In this study, the SER chronic bioassay has shown effects in individual-level 
endpoints, namely growth and behaviour. Despite no significant with effects being apparent 
on mortality nor in sex-ratio, an imbalance in sex ratio was visible, a higher prevalence of 
males in the highest tested concentrations (40, 200 and 1000 ng/L), being more pronounced 
at 40 ng/L SER concentration. This imbalance might be due to mortality, predation skewed 
towards females, and/or higher sensibility of females to SER exposure. A change in the 
normal sex-ratio (1:1), with a male prevalence, might lead to an alteration in the population’s 
structure.  
In this study, SER induced changes in G. locusta growth. Significant growth 
differences among SER treatments and between males and females were observed. Our 
results suggest non-monotonic responses. A U-shaped response was observed in males’ 
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growth where intermediate concentrations showed the lowest response, while extreme 
concentrations triggered a high response. Males’ growth response may be associated with 
a predominance of male-biased sex ratio. Carfagno and Fong (2014) observed that 
tadpoles Lithobates sylvaticus showed smaller sizes when raised among conspecific. 
Although, when the tadpoles were exposed to SER individually, no significant differences 
were found among the experimental groups. Therefore, SER exposure lead to smaller sized 
individuals when these are raised under more stressful conditions (Carfagno and Fong, 
2014). So, when males-biased sex ratio occurs, the males’ growth is lower, as a 
consequence of a more stressful environment. One explanation for these type of responses 
is the changes in social behaviour and competition imposed by males’ conspecifics. 
Interestingly, for females, the growth rate revealed significant differences in 8 ng/L where 
the females were larger than those in the 200 and 1000 ng/L. The growth reduction in 
females exposed to 200 and 1000 ng/L of  SER might be related to the energy allocation 
spent on  the organisms’ development to the antioxidant defences, necessary to reduce the 
SER effects (Neuparth et al., 2014a); or it can be connected to lower feed rate, as Conners 
et al., (2009) observed that tadpoles exposed to SSRIs ate less food than control tadpoles.  
The decline in growth rate of an organism might affect the population (Neuparth et 
al., 2014a). A lower growth rate leads to a reduced reproductive success due to lower 
fecundity and probably of matting. In addition it also reduces the  probability of escape from 
predators (Carfagno and Fong, 2014; Neuparth et al., 2014a). Additionally, if the number of 
females decreases and if they have a smaller size, it can lead to a smaller number of their 
offspring, thus affecting the population. Concerning the SSRIs exposure, it is described that 
SER provokes growth inhibition in algae (Minagh et al., 2009), causes lower growth in 
exposed tadpoles (Conners et al., 2009). Nevertheless, the mode of action behind these 
effects is not yet fully known (Conners et al., 2009).  
Concerning reproduction, in this study, we did not find significant differences. 
However, it has been demonstrated that the reproduction of aquatic organisms is affected 
by SSRIs exposure; nevertheless, the results are different between the diverse studies. 
Among the SSRIs, FLU appears to disrupt the endocrine system of several organisms, to 
induce spawning and oocyte maturation in mussels (Fong, 1998), promote parturition in 
fingernail clams (Fong and Molnar, 2008), alter the offspring production in cladocerans 
(Flaherty and Dodson, 2005), generate development abnormalities in embryos and produce 
variations in hormone levels in fish (Foran et al., 2004). Some studies showed that several 
reproductive assays carried out with SSRIs lead to non-monotonic responses (Brooks et 
al., 2003a; Flaherty and Dodson, 2005). This pattern was observed in spawning in zebra 
mussel (Fong, 1998), in the cumulated number of neonates per adult in the mollusc 
Potamopyrgus antipodarum (Gust et al., 2009) and on the brood size of C. dubia (Brooks 
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et al., 2003b). However, the results are not consistent between different studies. After one 
month of FLU exposure, no differences were found in medaka’s reproduction at 
concentrations between 0.1 – 5 µg/L (Foran et al., 2004), neither in the amphipod Hyalella 
azteca at 4 - 100 µg/L (Péry et al., 2008). The SER exposure lead to a reduction in the 
number of offspring produced by D. magna at 100 µg/L during 21 days of exposure (Minagh 
et al., 2009) and C. dubia at 45 µg/L during 8 days of exposure (Henry and Kwon, 2004). 
Modifications in serotonin levels can lead to different effects in different species (Foran et 
al., 2004). In invertebrates, the serotonin levels might disrupt the normal functioning of the 
endocrine system and reproductive parameters. Serotonin has the ability to modulate 
several hormones responsible for oogenesis and moulting. Particularly in crustaceans, the 
serotonin promotes the release of neurodepressing, gonad stimulating and moult-inhibiting 
hormones, among others (Daughton and Ternes, 1999; Flaherty and Dodson, 2005). Since 
the SSRI leads to an increase of serotonin, it is expected that the SSRI promotes 
reproduction in invertebrates (Flaherty and Dodson, 2005). However, the stimulation of 
reproduction does not occur in all studies. The SSRI seems to have different species-
specific responses on reproduction (Péry et al., 2008). Is necessary to consider that some 
of the differences might be caused by the different concentrations applied in the assays. 
In addition to the observed disturbance in growth, SER produced alterations on the 
behaviour of G. locusta noticed by a significant increase of females’ activity at the highest 
treatment level. An increase in Echinogammarus marinus activity was previously observed 
by Bossus et al. (2014) when this amphipod was exposed to 10 ng/L of SER during only 
one hour. In the present study no significant effects were observed on the behaviour of 
males. However, in females, a significant increase in locomotion was observed at the higher 
SER concentration tested (1000 ng/L). Since it is known that, in crustaceans, the serotonin 
regulates the neuro-hormones release (Daughton and Ternes, 1999), we believe that these 
behaviour differences between both genders should be due to sex-specific hormonal 
signalling. There are few studies about SSRI exposure that analysed sex differences. 
However, those that do, generally focus on males. Several changes in behavioural patterns 
after SSRI exposure have been described in the literature. Mesquita et al. (2011) observed 
an increase in males’ activity in a chronic 7 days FLU expose at 120 µg/L with crabs 
Carcinus maenas. Whereas Valenti et al, (2012) observed a reduction of shelter-seeking 
behaviour of fathead minnows males P. promelas during 21 days of SER exposure at 3 
µg/L. In contrast with to our results, non-monotonic responses on behaviour were described 
in numerous studies. This type of response was observed in fish and gammarids. In fathead 
minnow, males’ mating behaviour was affected when these were exposed to chronic FLU 
concentrations of 1 and 100 μg/L during 30 days. However, no differences were found at 
10 μg/L (Weinberger II and Klaper, 2014). Another example is Gammarus pulex; when 
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exposed to FLU at 0,1 ng/L – 1 mg/L range, it only showed a decrease in activity at 10 and 
100 ng/L (De Lange et al., 2006). These disparities might be associated with neuro-
hormones effects regulation, which may differ among groups  (Fong and Ford, 2014).  It is 
necessary to consider that the behavioural patterns analysed are not the same between the 
studies nor are the used species. Although the susceptibility of different species is an 
element to consider, there are others which are also relevant such as concentration and 
duration of exposure. More studies are needed to evaluate the impacts of SSRI chronic 
exposure at environmentally relevant concentrations on the organisms’ behaviour 
(Weinberger II and Klaper, 2014). In some SSRI exposure studies, the behaviour analyses, 
have been more useful than other individual endpoints, given that serotonin has been 
associated with behavioural changes in aquatic organisms like locomotion, mating, feeding 
and territorial behaviour (Conners et al., 2009; Henry and Kwon, 2004; Mesquita et al., 
2011; Weinberger II and Klaper, 2014). Among the behaviour patterns, locomotion has a 
high relevance considering that it is the base for acting on physiological needs such as food 
search, reproduction, among others (Mesquita et al., 2011). 
4.2 BIOCHEMICAL ENDPOINTS 
In this study, no significant differences were found in GST activity among 
experimental groups. Nevertheless, a variation in its activity was noted. The highest 
concentration tested showed 15% and 11% more activity in males and females, 
respectively, when compared to the control group. Since one metabolic pathway of 
elimination of SER is through its conjugation with glutathione, we expected a significant 
increase in GST activity after a SER exposure. Besides, previous studies showed that a 7 
days SER exposure significantly induced GST activity at 5 and 500 µg/L in crabs(Rodrigues 
et al., 2015) and at 21 and 116 µg/L in fish (Xie et al., 2015), which was not observed in the 
present study.  
CAT and SOD activities reflect the attempts of antioxidant defences in removing the 
ROS. SOD catalyses the conversion of superoxide radical to H2O2. Then, the H2O2 can be 
converted by CAT into water and oxygen (Valavanidis et al., 2006; Van der Oost et al., 
2003; Xie et al., 2015). In the present study, a distinct antioxidant response was noticed 
between genders. SER significantly decreased SOD activity, in males. A reduction of SOD 
activity was also seen, in FLU exposures, in Asian clam Corbicula fluminea at 5 µg/L for 30 
days of exposure (Chen et al., 2015) and in mussels Mytillus galloprovincialis at 75 ng/L for 
15 days of exposure (Gonzalez-Rey and Bebianno, 2013). Despite the fact that SOD was 
depressed in the highest concentrations, in this study, no significant differences were 
observed in males’ CAT activity. Rodrigues et al. (2015) propose that SSRI may lead to an 
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inhibition of antioxidant defences. This hypothesis was explored in several studies which 
documented that high levels of ROS, originated from FLU exposure, may have lead to a 
SOD depletion (Gonzalez-Rey and Bebianno, 2013). An increased presence of superoxide 
radicals is detected with the reduced activity of SOD. These radicals, if not eliminated, can 
compromise cell integrity and homeostasis (Djordjevic et al., 2011). In females, a significant 
decrease of CAT activity occurred at the lowest concentration tested (8 ng/L) when 
comparing with the highest (1000 ng/L), confirming a non-monotonic response. An increase 
of CAT activity was also observed, in SER exposures, at 0.05 µg/L in crabs C. maenas for 
7 days of exposure (Rodrigues et al., 2015), at 5 µg/L in Asian clam C. fluminea when 
exposed for 30 days (Chen et al., 2015) and at 4.36 µg/L  in goldfish C. auratus for 7 days 
of exposure (Xie et al., 2015). Based on results and in literature data, we can conclude that 
SER may cause oxidative stress to non-target organisms, and these organisms attempt to 
eliminate this condition by increasing their antioxidant defences, namely the CAT activity. 
Nevertheless, females’ CAT induction may also occur due to factors related with 
reproduction or moulting cycles (Correia et al., 2003). In these situations, the oxygen 
consumption increases, favouring the formation of ROS (Correia et al., 2003).   
When the antioxidant defences are not capable of surpassing the ROS effects, 
oxidative damage occurs. The LPO is probably the most studied biomarker of oxidative 
damage. It leads to lipid fragmentation, producing diverse reactive products, mostly 
aldehydes (Del Rio et al., 2005; Van der Oost et al., 2003). MDA is the aldehyde most 
formed (Del Rio et al., 2005; Valavanidis et al., 2006). In this study, a slight increase of MDA 
content occurred in males, at the concentration of 200 ng/L, when compared to the highest 
concentration. This indicate that antioxidant defences of G. locusta are insufficient to 
eliminate the ROS damage. Results suggest that the increase of MDA content is connected 
with a visible reduction of males’ activity of CAT and GST, at this concentration (200 ng/L). 
A significant increase of MDA content was found in FLU exposures, like with C. fluminea at 
5 µg/L after 30 days (Chen et al., 2015) and with marine mussel M. galloprovincialis at 75 
ng/L after 7 days of exposure (Gonzalez-Rey and Bebianno, 2013). However, fluoxetine-
exposed mussel M. galloprovincialis at 0-300 ng/L showed a reduction MDA content, only 
at concentrations of 0.3 and 30 ng/L (Franzellitti et al., 2014). Taking this into account, the 
possibility of a non-monotonic response, depending on the concentration or used organism, 
seems plausible. 
The AChE catalyses the cleavage of acetylcholine into choline and acetic acid in the 
cholinergic synapses and neuromuscular junctions (Lionetto et al., 2003; Xuereb et al., 
2009). This enzyme has been used as a biomarker of neurotoxicity (Munari et al., 2014; Xie 
et al., 2015), since its inhibition leads to an overstimulation of the nervous system, 
subsequently originating harmful effects for the organism (Xuereb et al., 2009a). In this 
 
 
30 
 
study, no significant effects were observed in AChE activity. The results obtained in the 
present study are unexpected, since it is likely that SER mode of action interferes with AChE 
activity (Xie et al., 2015). Numerous studies have demonstrated that AChE activity of 
Gammarus sp. is inhibited by pesticides (Xuereb et al., 2009b) and silver nanoparticles 
(Shirvani et al., 2013). There are not any studies that show changes in the AChE activity in 
this genus when exposed to pharmaceuticals. However, previous studies have shown that 
AChE activity is affected by SSRI exposure in other organisms. Munari et al. (2014) 
detected a decrease of AChE activity when the clam Venerupis philippinarum was exposed 
to 1 and 5 µg/L of FLU at during 7 days, while AChE activity returned to control values in  
higher FLU concentrations (Munari et al., 2014). Conversely, AChE activity in crabs C. 
maenas showed an increase after 7 days of exposure to FLU only at 120 and 750 µg/L. 
Concerning SER exposure, in the fish C. auratus at 4.36 and 21.3 µg/L an increase of AChE 
activity was noted after 7 days of SER exposure, but at 116 µg/L no differences were found 
(Xie et al., 2015). These findings suggest that SSRI might affect the AChE activity 
depending on the concentration, exposure duration and on the species analysed.  
4.3 SERTRALINE QUANTIFICATION 
The data shows that there are differences in the actual and nominal concentrations 
of SER. These variations might be due the potential binding of SER to the aquaria (Bossus 
et al., 2014). Another hypothesis is that the presence of the sediment layer affect the 
availability of SER, since this compound shows high sorption coefficient (log koc = 4.17) 
which indicates its tendency to bind to the sediment (Silva et al., 2012).  
The extraction procedure rendered recovery rates between 49 and 78%, although 
moderately low, the other parameters of validation (precision and accuracy) have 
acceptable values (de Castro et al., 2008). Therefore, for further studies, the extraction 
methodology needs to be improved in order to increase the recovery values. 
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5 CONCLUSIONS AND FUTURE WORK 
Overall, this study revealed that the chronic exposure of G. locusta to SER at   
environmentally relevant concentrations caused an impact at ecological and biochemical 
endpoints. A non-monotonic response was detected in growth and in the activity of some 
biomarkers. These results are comparable to that of previous findings regarding other 
antidepressants. The most predominant effect of SER was verified in the behavioural 
analysis that revealed a signiﬁcant increase of females’ activity at the highest concentration 
tested.  
Considering the results obtained in this study, further studies should be performed 
in order to understand the mode of action of SER and the molecular mechanisms involved 
in the observed effects to better determine their environmental impact. It would be also 
interesting to further investigate long-term multigenerational SER exposure and determine 
the cause for different responses between sexes. An evaluation of the potential effect of 
SER exposure on the dynamics of G. locusta population would also be important as a 
means to verify the ecological consequences of SER in aquatic ecosystems. From an 
ecological point of view, it is also important to ascertain the SER effects in different phyla 
with the goal of improving the knowledge on the impacts at the ecosystem level as well as 
investigate if its mechanisms of action across different taxonomic groups are conserved. 
Given that the pharmaceuticals are not present individually in the environment, it is 
important to investigate their mixture’ effects in long-term exposures. 
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